Delivery Order SPE2DB24D2205-SPE2DB24FDWJG
Award Date
7/2/24
Potential Completion Date
7/3/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,359,392 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,937.74 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen, one of the largest pharmaceutical distribution companies...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, Fluticasone Prop HFA 220 MCG 12GM, to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price of $4,613.45 and an ultimate completion date of April 30, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The $15,436.60 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer for Amerisourcebergen. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 30, 2024. This award is likely part of a larger indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract, valued at $1,035.80, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of May 29, 2024. The contract was awarded without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,238.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 3, 2024 and does not include a set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,047,320 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The $7,826.62 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This contract is not a set-aside and is part of a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,442.56 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on July 15, 2024, with a completion date of July 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "FLUTICASONE PROP HFA 44 MCG 10.6GM." The contract, valued at $1,368.96, is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The contract, valued at $1,016.36, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...